Pentabase
PentaBase is a Danish IVD company that develops CE-IVD/IVDR certified PCR assays for oncology and haematology diagnostics based on its proprietary INA® nucleic acid chemistry, serving clinical laboratories worldwide through direct sales, e-commerce, and a distributor network.
- Company typePrivate
- Founded2006
- HeadquartersOdense, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pentabase does
PentaBase is a Danish in vitro diagnostics company founded in 2006 and headquartered in Odense, Denmark. The company develops molecular diagnostic PCR assays and laboratory instruments for cancer detection and monitoring, built on its proprietary INA® (Intercalating Nucleic Acid) chemistry platform. INA®-based oligonucleotides incorporate covalently linked intercalating pseudo-nucleotides (IPNs) that increase π-stacking to deliver higher target affinity, specificity, and lower background fluorescence relative to standard DNA oligos, and the same chemistry underpins the company's probes, primers, and assays.
The portfolio is organized into three categories: (i) CE-IVD certified clinical assays for oncology and haematology, including SensiScreen FFPE and Liquid qPCR assays for somatic mutations (EGFR, BRAF, KRAS, NRAS, KIT, PIK3CA), EpiDirect MGMT and MLH1 methylation qPCR assays that bypass bisulfite conversion, MicroSight MSI for microsatellite instability via HRM, and PlentiPlex MYD88 and KIT for haematological malignancies; (ii) custom oligonucleotide reagents sold as research inputs (HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, BaseBlockers); and (iii) laboratory instruments with associated consumables, including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier magnetic-bead extraction systems (32, 48, 96), and PANA 9600S and DC48 automated workstations. Most assays are validated as open-platform on third-party instruments from Bio-Rad, Applied Biosystems, Qiagen, Agilent, and IT-IS Life Science.
PentaBase commercializes through direct sales, an e-commerce storefront (shop.pentabase.com), and an authorized distributor network spanning more than 14 countries across Europe, Asia, the Middle East, and Oceania. Pricing is predominantly quote-based for assays and instruments, with unit-pricing published for certain oligonucleotides (e.g., BaseBlockers at €140-€500). In January 2026 the company obtained EU IVDR Class C certification (Certificate No. IVDR 790049 R000 from BSI Group, valid through January 2031) covering its IVD PCR assay portfolio. The company is privately held as PentaBase A/S (CVR 30 19 78 52) with no disclosed institutional investors or funding rounds, appearing to be founder/owner-operated with reported headcount of 1-10 employees.
Pentabase firmographics
Firmographics- Name
- Pentabase
- Legal name
- PentaBase A/S
- Website
- https://pentabase.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PentaBase is a Danish IVD company that develops CE-IVD/IVDR certified PCR assays for oncology and haematology diagnostics based on its proprietary INA® nucleic acid chemistry, serving clinical laboratories worldwide through direct sales, e-commerce, and a distributor network.
- Ownership category
- akta.pro rank
Pentabase industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Pentabase is headquartered
LocationHeadquarters
- HQ city
- Odense
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
Pentabase business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Others
Revenue model
- IVD PCR Assays: Sale of CE-IVD certified PCR assays for oncology and haematology diagnostics including SensiScreen®, EpiDirect®, PlentiPlex™, and MicroSight® product families. These are the primary revenue drivers targeting clinical laboratories worldwide.
- Instruments and Extraction Kits: Sale of laboratory instruments including BasePurifier™ nucleic acid extraction systems and BaseTyper™ real-time PCR instruments, along with compatible extraction kits. Hardware sales with associated consumables.
- Custom Oligonucleotides: Sale of customized INA®-based and standard oligonucleotides including probes, primers, and specialty oligos. Customers can order custom-designed products for specific PCR applications.
- Assay Development Services: Fast development service for custom tumor-informed dPCR and qPCR assays for MRD (Minimal Residual Disease) testing. Custom assays designed and produced on demand, shipped within 4 weeks.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Custom Oligonucleotides - BaseBlockers™ |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Pentabase product offering
Product offeringCore offering
PentaBase develops and manufactures CE-IVD certified PCR-based in vitro diagnostic assays, instruments, and custom oligonucleotides for cancer detection and monitoring. Its proprietary INA® (Intercalating Nucleic Acid) chemistry underpins products for somatic mutation detection in FFPE and liquid biopsies, DNA methylation analysis, microsatellite instability testing, and haematology diagnostics, complemented by automated nucleic acid extraction systems and real-time PCR instruments.
Product overview
Pentabase is a Danish in vitro diagnostics company offering a comprehensive molecular diagnostics portfolio centered on proprietary INA (Intercalating Nucleic Acid) technology. The product portfolio spans three main categories: (1) CE-IVD certified PCR assays including SensiScreen FFPE and Liquid qPCR assays for somatic cancer mutation detection, EpiDirect MGMT/MLH1 methylation assays for direct conversion-free DNA methylation analysis, MicroSight MSI for microsatellite instability evaluation, and PlentiPlex MYD88/KIT for haematology applications; (2) Custom oligonucleotides including HydrolEasy probes, EasyBeacon probes, SuPrimers, EpiPrimers, and BaseBlockers that form the technological backbone of all assays; (3) Instruments including BaseTyper real-time PCR systems (48.4 and 96.4/6), BasePurifier nucleic acid extraction systems (32, 48, 96), DC48 and PANA 9600S automated workstations, and BaseSNAP extraction kits. All products leverage INA technology for enhanced target affinity, specificity, and reduced background fluorescence. The instruments and assays are designed as open platforms compatible with standard real-time PCR instruments from major vendors.
Differentiator
Problem solved
Functional benefit
Brands
- SensiScreen®: IVD PCR assays for somatic cancer mutations detection in FFPE and liquid biopsies
- EpiDirect®
- PlentiPlex™
- MicroSight® MSI
- BaseTyper™
- BasePurifier™
- BaseSNAP™
- BaseBlockers™
- HydrolEasy®
- EasyBeacon™
- SuPrimers™
- EpiPrimers™
- PANA 9600S
- DC48
Quantifiable outcome
- EpiDirect® MGMT detects methylation levels as low as 1.5%
- +4 more outcomes
Companies that use Pentabase
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Pentabase technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration29 records
AI capability6 records
Feature8 records
Pentabase partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core.
- Altium Česká republika / Altium InternationalcoreDistributor for Czech Republic and Croatia, Bosnia, Herzegovina, and Serbia markets. Provides local access to PentaBase's molecular diagnostics and PCR solutions.
- AnaChem DiagnosticscoreDistributor for Greece, providing local access to PentaBase's IVD assays and life science products.
- BIONIX LABcoreDistributor for Ukraine, providing local access to PentaBase's molecular diagnostics products.
- Calibre ScientificcoreDistributor for France, providing local access to PentaBase's PCR solutions and molecular diagnostics.
- LabemacoreDistributor for Finland, providing local access to PentaBase's IVD assays and instruments.
- DextercoreDistributor for Romania, providing local access to PentaBase's molecular diagnostics products.
- DYNEXcoreDistributor for Slovakia, providing local access to PentaBase's PCR solutions.
- Genom Saglik UrunlericoreDistributor for Turkey, providing local access to PentaBase's molecular diagnostics.
- HiSS DiagnosticscoreDistributor for Germany and Austria, providing local access to PentaBase's IVD assays and instruments.
- ResnovacoreDistributor for Italy, providing local access to PentaBase's PCR solutions.
- RidacomcoreDistributor for Bulgaria, providing local access to PentaBase's molecular diagnostics products.
- Micro SolutionscoreDistributor for Kazakhstan, providing local access to PentaBase's IVD assays.
- SEDEERcoreDistributor for Qatar, providing local access to PentaBase's molecular diagnostics.
- Ngaio DiagnosticscoreDistributor for New Zealand, providing local access to PentaBase's PCR solutions and instruments.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Pentabase competitors and assessment
Company assessmentDirect peers
- Qiagen: Global molecular diagnostics leader offering real-time PCR kits, sample-preparation instruments, and oncology assays. Direct competitor in PCR-based mutation detection and methylation testing; PentaBase validates on Qiagen's Rotor-Gene Q, underscoring product overlap.
- Vela Diagnostics: Singapore-headquartered molecular diagnostics company providing PCR and NGS oncology and infectious disease kits with IVD regulatory clearances. Comparable in offering CE-IVD oncology PCR assays to clinical labs globally.
- Diatech Pharmacogenetics: Italian molecular diagnostics company specializing in CE-IVD real-time PCR kits for oncology and pharmacogenetics. Comparable in CE-IVD oncology assay portfolio, European market focus, and clinical-lab customer base.
- Amoy Diagnostics: China-based oncology molecular diagnostics company offering real-time PCR and NGS-based companion diagnostic kits for EGFR, KRAS, BRAF, and other targets. Directly comparable menu and clinical-lab customer base to PentaBase's SensiScreen line.
- Bio-Rad Laboratories: Manufacturer of real-time PCR instruments (CFX96, CFX Opus) and an extensive portfolio of PCR reagents and ddPCR systems. Directly comparable in oncology qPCR reagents and instrument platforms that PentaBase's assays are validated to run on.
- Biocartis: Belgium-based molecular diagnostics company commercializing the Idylla™ fully automated PCR platform with oncology mutation panels. Directly comparable in offering CE-IVD oncology PCR assays to clinical laboratories in Europe.
- EntroGen: Developer of real-time PCR-based oncology and hematology diagnostic kits for clinical laboratories. Comparable menu (KRAS, BRAF, EGFR, JAK2, BCR-ABL) and CE-IVD regulatory positioning to PentaBase.
Broad incumbents
- Thermo Fisher Scientific (Applied Biosystems): Diversified life-sciences giant with the QuantStudio and ABI 7500 real-time PCR instruments, plus oncology molecular diagnostic content. PentaBase assays are validated on QuantStudio 5 and ABI 7500, reflecting direct platform competition.
Emerging players
- Stilla Technologies: Specialist in digital PCR (naica® system) for oncology liquid biopsy and rare-mutation detection. Comparable to PentaBase's BaseBlockers-enabled low-frequency SNV detection in liquid biopsy workflows.
- IT-IS Life Science (MyGo): Manufacturer of the compact MyGo Pro real-time PCR instrument, which PentaBase validates extensively across SensiScreen assays. Closely intertwined through instrument/assay co-validation, making MyGo both a partner and a potential instrument-competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Pentabase social profiles
Digital presencePentabase compliance and trust
Trust signalCompliance3 records
Pentabase financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pentabase leadership team
Management profileNumber of profiles
Pentabase funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pentabase M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pentabase
What does Pentabase do?
PentaBase develops and manufactures CE-IVD certified PCR-based in vitro diagnostic assays, instruments, and custom oligonucleotides for cancer detection and monitoring. Its proprietary INA® (Intercalating Nucleic Acid) chemistry underpins products for somatic mutation detection in FFPE and liquid biopsies, DNA methylation analysis, microsatellite instability testing, and haematology diagnostics, complemented by automated nucleic acid extraction systems and real-time PCR instruments.
Is Pentabase a public or private company?
Pentabase is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pentabase founded?
Pentabase was founded in 2006. It employs 1 to 10 people.
Where is Pentabase based?
Pentabase is headquartered in Odense, Denmark, in the Europe region.
How does Pentabase make money?
Four revenue lines are on record. IVD PCR Assays are the primary driver. The others are instruments and Extraction Kits, custom Oligonucleotides and assay Development Services.
Who are Pentabase's main competitors?
Direct peers on record are Qiagen, Vela Diagnostics, Diatech Pharmacogenetics, Amoy Diagnostics, Bio-Rad Laboratories, Biocartis and EntroGen. Thermo Fisher Scientific (Applied Biosystems) is listed as a broad incumbent. Emerging players are Stilla Technologies and IT-IS Life Science (MyGo).
Does Pentabase have an API?
No public API is recorded for Pentabase.
What industry is Pentabase in?
Pentabase's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.